Top Tweets for #CheapDrugs

Attention $KRTL shareholders: We’ve implemented MasterControl QMS to streamline future mergers by unifying quality processes, automating compliance, and enhancing workforce training. This ensures consistency, mitigates risks, and drives operational excellence. PR with more details to come. #KRTL #Mergers #QMS

$KRTL has strategically positioned itself in Bolivia because it has an abundant biodiversity, which could be a valuable resource for API production, especially for plant-based or naturally derived pharmaceutical ingredients. Setting up infrastructure there could provide several strategic advantages for the U.S. market: 1.Diversification from China & India: By establishing an API supply chain in Bolivia, KRTL reduces dependency on traditional pharmaceutical hubs and mitigates risks from tariffs or geopolitical tensions. 2.Access to Unique Natural Resources: Bolivia’s rainforests and Andean ecosystems offer a rich source of bioactive compounds that could be leveraged for novel drug development. 3.Cost-Effective Production: Labor and operational costs in Bolivia are lower than in the U.S. or Europe, making it a financially attractive option for pharmaceutical manufacturing.